MF Wendel SE

WENDEL: Wendel announces the completion of its €200 million share repurchase programme

WENDEL: Wendel announces the completion of its €200 million share repurchase programme

The €200 million share repurchase agreement entered on March 26, 2019, with Goldman Sachs International (“Goldman Sachs”), initiated on April 17, 2019, was completed on December 17, 2019.

Between April 17, 2019 and December 17, 2019, in the context of this programme, Wendel acquired a total of 1,645,338 ordinary shares (representing 3.55% of outstanding shares count before the launch of the programme) at an average adjusted price of €121.5555.

As a reminder, on April 23, 2019, Wendel made a €200 million payment to Goldman Sachs and received 1,169,399 of its own ordinary shares. These shares were canceled on April 25, 2019.

Upon completion of the agreement, Wendel received from Goldman Sachs 475,939 additional ordinary shares. This additional number of shares has been determined on the basis of the volume-weighted average price per share, less a discount, over the execution period. The additional 475,939 ordinary shares were delivered on December 19, 2019 were canceled on the same day.

Wendel capital will thus be composed of 44,682,308 shares.

It is recalled that the 913,184 shares currently held in treasury acquired prior to this share repurchase agreement and allocated to other objectives, are not intended to be cancelled.

The liquidity contract, which had been suspended since April 17, 2019, will resume its activity starting from December 20, 2019.

Agenda

03.18.2020

2019 FY Results / Publication of NAV of December 31, 2019 (post-market release)

04.30.2020

Q1 2020 Trading update / Publication of NAV as of March 31, 2020 (pre-market release).

06.04.2020

2020 Annual General Meeting

07.30.2020

H1 2020 results / Publication of NAV as of June 30, 2020, and condensed Half-Year consolidated financial statements (post-market release).

11.04.2020

2020 Investor Day / Presentation of NAV as of September 30, 2020, and Q3 2019 trading update (publication post-market release on 11/03/2020).

Attachment

EN
19/12/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wendel SE

 PRESS RELEASE

WENDEL: Share buybacks and liquidity agreement suspension

WENDEL: Share buybacks and liquidity agreement suspension   SHARE BUYBACKS – FEBRUARY 27, 2026 Share buybacks and liquidity agreement suspension As announced yesterday, Wendel signed today a mandate with Natixis SA, in its capacity as investment services provider, for share buybacks up to a maximum volume representing approximately 9% of the share capital. The mandate is effective for a period that may extend until December 18, 2026 inclusive. These share buybacks will be carried out under the share buyback program authorized by the Shareholders’ Meeting of May 15, 2025, as renewed, a...

 PRESS RELEASE

WENDEL : Rachat d’actions et suspension du contrat de liquidité

WENDEL : Rachat d’actions et suspension du contrat de liquidité RACHAT D’ACTIONS – 27 FEVRIER 2026 Rachat d’actions et suspension du contrat de liquidité Comme annoncé hier, Wendel a signé ce jour avec Natixis SA, en sa qualité de prestataire de services d’investissement, un mandat portant sur le rachat de ses propres actions pour un volume maximum représentant environ 9% du capital. Le mandat est effectif pour une durée pouvant s’étendre jusqu’au 18 décembre 2026 inclus. Ces rachats seront effectués dans le cadre du Programme de rachat d’actions autorisé par l’Assemblée Générale du 15 ...

Carole Braudeau
  • Carole Braudeau

Credit Morning 02/27/2026

INEOS Quattro: conference call comments|NIH: improvement in certain indicators in H2, but still little visibility on M&A|Ardagh Group surprises with strong increase in glass EBITDA in Q4|Clariane : Satisfactory 2025 results thanks to strong recovery in H2 25 and B2/B+ ratings assigned by Moody’s and S&P|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 27/02/2026

INEOS Quattro: conference call comments|NIH : amélioration de certains indicateurs au S2 mais toujours peu de visibilité sur le M&A|Ardagh Group surprend avec une forte hausse de l’EBITDA verre au T4|Clariane : Résultats 2025 satisfaisants grâce à un bon rattrapage au 2nd semestre et ratings B2/B+ attribués par Moody’s et S&P|

ResearchPool Subscriptions

Get the most out of your insights

Get in touch